Literature DB >> 23743315

Social, economic, and psychological impacts of MDR-TB treatment in Tijuana, Mexico: a patient's perspective.

M D Morris1, L Quezada, P Bhat, K Moser, J Smith, H Perez, R Laniado-Laborin, J Estrada-Guzman, T C Rodwell.   

Abstract

SETTING: The State of Baja California, Mexico, had the highest prevalence of multidrug-resistant tuberculosis (MDR-TB) in Mexico in 2009.
OBJECTIVE: To understand the socio-economic burden of MDR-TB disease and its treatment on patients in Tijuana and Mexicali, Mexico.
DESIGN: From July to November 2009, qualitative interviews were conducted with 12 patients enrolled in a US-Mexico binational MDR-TB treatment program, Puentes de Esperanza (Bridges of Hope), which was designed to support MDR-TB patients. In-depth interviews were coded to identify major themes in patient experiences of MDR-TB diagnosis and care.
RESULTS: While some patients were able to maintain their pre-MDR-TB lives to a limited extent, most patients reported losing their sense of identity due to their inability to work, social isolation, and stigmatization from family and friends. The majority of participants expressed appreciation for Puentes' role in 'saving their lives'.
CONCLUSION: Being diagnosed with MDR-TB and undergoing treatment imposes significant psychological, social and economic stress on patients. Strong social support elements within Puentes helped alleviate these burdens. Improvements to the program might include peer-support groups for patients undergoing treatment and transitioning back into the community after treatment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23743315      PMCID: PMC3769163          DOI: 10.5588/ijtld.12.0480

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  8 in total

1.  Survey of drug resistance of Mycobacterium tuberculosis in 3 Mexican states, 1997.

Authors:  R M Granich; S Balandrano; A J Santaella; N J Binkin; K G Castro; A Marquez-Fiol; G Anzaldo; M Zarate; M L Jaimes; O Velazquez-Monroy; L Salazar; C Alvarez-Lucas; P Kuri; A Flisser; J Santos-Preciado; C Ruiz-Matus; R Tapia-Conyer; J W Tappero
Journal:  Arch Intern Med       Date:  2000-03-13

2.  Compliance, coercion, and compassion: moral dimensions of the return of tuberculosis.

Authors:  Michael J Booker
Journal:  J Med Humanit       Date:  1996

3.  Role of surgery in pulmonary multidrug-resistant tuberculosis.

Authors:  L Peter Ormerod
Journal:  Thorax       Date:  2007-05       Impact factor: 9.139

4.  What do cancer support groups provide which other supportive relationships do not? The experience of peer support groups for people with cancer.

Authors:  Jane Ussher; Laura Kirsten; Phyllis Butow; Mirjana Sandoval
Journal:  Soc Sci Med       Date:  2005-11-21       Impact factor: 4.634

Review 5.  Treatment of multidrug-resistant tuberculosis.

Authors:  M D Iseman
Journal:  N Engl J Med       Date:  1993-09-09       Impact factor: 91.245

6.  Treatment of multidrug-resistant tuberculosis in a high-prevalence region through a binational consortium.

Authors:  R Laniado-Laborín; J Estrada-Guzman; H Perez; F Batiz-Armenta; J M Alcantar-Schramm
Journal:  Int J Tuberc Lung Dis       Date:  2012-03-07       Impact factor: 2.373

Review 7.  Drug resistant Mycobacterium tuberculosis in Mexico.

Authors:  Jorge Zazueta-Beltran; Claudia León-Sicairos; Adrián Canizalez-Roman
Journal:  J Infect Dev Ctries       Date:  2009-04-30       Impact factor: 0.968

Review 8.  The clinical management of drug-resistant tuberculosis.

Authors:  Jennifer Furin
Journal:  Curr Opin Pulm Med       Date:  2007-05       Impact factor: 3.155

  8 in total
  22 in total

1.  Disadvantage and the Experience of Treatment for Multidrug-Resistant Tuberculosis (MDR-TB).

Authors:  Holly A Taylor; David W Dowdy; Alexandra R Searle; Andrea L Stennett; Vadim Dukhanin; Alice A Zwerling; Maria W Merritt
Journal:  SSM Qual Res Health       Date:  2022-01-28

2.  Internalized and Perceived Stigma and Depression in Pulmonary Tuberculosis: Do They Explain the Relationship Between Drug Sensitivity Status and Adherence?

Authors:  Anmol Pradhan; Prakash Koirala; Samrat Singh Bhandari; Sanjiba Dutta; Pau García-Grau; Harshavardhan Sampath; Indralal Sharma
Journal:  Front Psychiatry       Date:  2022-05-19       Impact factor: 5.435

3.  Magnitude of Depression and Associated Factors Among Patients on Tuberculosis Treatment at Public Health Facilities in Harari Regional State, Eastern Ethiopia: Multi-Center Cross-Sectional Study.

Authors:  Shame Abdurahman; Tesfaye Assebe Yadeta; Dasalegn Admassu Ayana; Mohammed Abdurke Kure; Jemal Ahmed; Ame Mehadi
Journal:  Neuropsychiatr Dis Treat       Date:  2022-07-11       Impact factor: 2.989

Review 4.  Medicinal chemistry of acridine and its analogues.

Authors:  Parteek Prasher; Mousmee Sharma
Journal:  Medchemcomm       Date:  2018-08-14       Impact factor: 3.597

5.  Follow-up examinations: are multidrug-resistant tuberculosis patients in Uttar Pradesh, India, on track?

Authors:  U C Tripathi; S B Nagaraja; J P Tripathy; S K Sahu; M Parmar; K Rade; S Bhatnagar; A Ranjan; K S Sachdeva
Journal:  Public Health Action       Date:  2015-03-21

6.  Major Depression and Stigma among Individuals with Multidrug-Resistant Tuberculosis in South Africa.

Authors:  Thirusha Naidu; Suntosh R Pillay; Suvira Ramlall; Sbusisiwe Sandra Mthembu; Nesri Padayatchi; Jonathan K Burns; Andrew Tomita
Journal:  Am J Trop Med Hyg       Date:  2020-09       Impact factor: 3.707

7.  Adverse Outcomes after Non-Chest Surgeries in Patients with Pulmonary Tuberculosis: A Nationwide Study.

Authors:  Chi-Chen Ke; Chao-Shun Lin; Chun-Chieh Yeh; Chi-Li Chung; Chih-Jen Hung; Chien-Chang Liao; Ta-Liang Chen
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

8.  Hospitalized care for MDR-TB in Port Harcourt, Nigeria: a qualitative study.

Authors:  Kingsley Lezor Bieh; Ralf Weigel; Helen Smith
Journal:  BMC Infect Dis       Date:  2017-01-10       Impact factor: 3.090

9.  Estimating the burden of antimicrobial resistance: a systematic literature review.

Authors:  Nichola R Naylor; Rifat Atun; Nina Zhu; Kavian Kulasabanathan; Sachin Silva; Anuja Chatterjee; Gwenan M Knight; Julie V Robotham
Journal:  Antimicrob Resist Infect Control       Date:  2018-04-25       Impact factor: 4.887

Review 10.  Psycho-Socio-Economic Issues Challenging Multidrug Resistant Tuberculosis Patients: A Systematic Review.

Authors:  Beena Elizabeth Thomas; Poonguzhali Shanmugam; Muniyandi Malaisamy; Senthanro Ovung; Chandra Suresh; Ramnath Subbaraman; Srividya Adinarayanan; Karikalan Nagarajan
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.